HOME Top Market Reports Preclinical Imaging (In-VIVO) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global Forecast to 2021

Preclinical Imaging (In-VIVO) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: August 2016
Report Code: MD 3117

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global preclinical imaging market is estimated to reach USD 910.4 Million by 2021; growing at a CAGR of 6.2% during the forecast period. The technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches are some key factors fueling the growth of the market. Furthermore, emerging markets such as China, India, South Korea, and Taiwan are offering new growth opportunities for market players. However, factors such as strict regulatory framework that governs preclinical researches, and significant installation and operational costs associated with preclinical imaging modalities are hampering the market growth.

Emerging markets (such as China and India) are offering high growth opportunities for market players operating in the preclinical imaging industry. Continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries are the key factors propelling the demand for preclinical imaging products in emerging nations. In order to leverage the high growth opportunities in these emerging nations, leading market players are expanding their presence in these countries.

As of 2015, PerkinElmer Inc. (U.S.) held the leadership position in the global preclinical imaging market. Over the past three years, the company has adopted new product launches, product enhancements, and geographic expansion as its key business strategies to ensure its dominance in this market. Bruker Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), Aspect Imaging (Israel), LI-COR Biosciences (U.S.), Trifoil Imaging (U.S.) and Miltenyi Biotec GmbH (Germany) are some of the other key players in this market.

Target Audience

  • Preclinical Imaging Instrument Manufacturers, Suppliers, and Imaging Software Providers
  • Pharmaceutical and Biotechnology Companies
  • Preclinical Imaging Reagent Manufacturers and Suppliers
  • Contract Research Organizations (CROs)
  • Research and Development (R&D) Companies
  • Government Research Laboratories
  • Independent Research Laboratories
  • Government and Independent Regulatory Authorities
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories
  • Academic Medical Institutes and Universities

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the preclinical imaging market into the following segments:

Preclinical Imaging Market, by Modality

  • Optical Imaging Systems
    • Bioluminescence/Fluorescence Imaging Systems
    • Standalone Fluorescence Imaging Systems
    • Optical + X-Ray/Optical + CT
  • Preclinical Nuclear Imaging Systems
    • Micro-PET Systems
    • Micro-SPECT Systems
    • Trimodality (SPECT/PET/CT) Systems
  • Micro-MRI Systems
  • Micro-Ultrasound Systems
  • Micro-CT Systems
  • Preclinical Photoacoustic Imaging Systems
  • Preclinical Magnetic Particle Imaging (MPI) Systems

Preclinical Imaging Market, by Reagents

  • Preclinical Optical Imaging Reagents
    • Bioluminescent Imaging Reagents
    • Fluorescent Imaging Reagents
  • Preclinical Nuclear Imaging Reagents
    • Preclinical PET Tracers
    • Preclinical SPECT Probes
  • Preclinical MRI Contrast Agents
    • Gadolinium-based Preclinical MRI Contrast Agents
    • Iron-based Preclinical MRI Contrast Agents
    • Manganese-based Preclinical MRI Contrast Agents
  • Preclinical Ultrasound Contrast Agents
  • Preclinical CT Contrast Agents
    • Iodine-based Preclinical CT Contrast Agents
    • Barium-based Preclinical CT Contrast Agents
    • Gold Nanoparticles
    • Gastrografin-based Preclinical CT Contrast Agents

Preclinical Imaging Market, by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Availabl Customization

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for preclinical imaging market report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies

Geographical Analysis

  • Further breakdown of the North American preclinical imaging market into the U.S. and Canada
  • Further breakdown of the European preclinical imaging market into Germany, France, and the U.K.
  • Further breakdown of the APAC preclinical imaging market into Japan, China, India, and Rest of APAC (RoAPAC)

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Preclinical Imaging Market Definition
    1.3 Preclinical Imaging Market Scope
           1.3.1 Markets Covered
                    1.3.1.1 Preclinical Imaging Market Segmentation
                    1.3.1.2 Preclinical Imaging Systems Market Segmentation
                    1.3.1.3 Preclinical Imaging Reagents Market Segmentation
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 21)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Preclinical Imaging Market Size Estimation
                    2.2.1.1 Bottom-Up Approach
                    2.2.1.2 Top-Down Approach
    2.3 Preclinical Imaging Market Breakdown and Data Triangulation
    2.4 Research Assumptions & Limitations
           2.4.1 Assumptions

3 Executive Summary (Page No. - 30)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 34)
    4.1 Global Preclinical Imaging Market Overview
    4.2 Preclinical Imaging Products Market Share, By Region (2016)
    4.3 Global Preclinical Imaging Systems Market, By Modality (2016–2021)
    4.4 Global Preclinical Imaging Reagents Market, By Type (2016–2021)
    4.5 Preclinical Imaging Market, By Region (2016 vs 2021)

5 Preclinical Imaging Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Preclinical Imaging Market Dynamics
           5.2.1 Key Market Drivers
                    5.2.1.1 Technological Advancements in the Field of Molecular Imaging
                    5.2.1.2 Increasing Market Demand for Noninvasive Small-Animal Imaging Techniques
                    5.2.1.3 Growing Number of Public-Private Initiatives and Funding to Support Preclinical Researches
           5.2.2 Key Market Restraints
                    5.2.2.1 Strict Regulations Governing Preclinical Research
                    5.2.2.2 Significant Installation and Operational Costs Associated With Preclinical Imaging Modalities
           5.2.3 Key Market Opportunity
                    5.2.3.1 Emerging Markets to Offer New Growth Opportunities
           5.2.4 Key Market Challenge
                    5.2.4.1 Technological and Procedural Limitations Associated With Standalone Preclinical Imaging Systems

6 Industry Insights (Page No. - 46)
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Supply Chain Analysis
           6.3.1 Key Stakeholders
           6.3.2 Key Influencers
    6.4 Industry Trends
           6.4.1 Ongoing Development of Hybrid and Multi-Modality Preclinical Imaging Systems
    6.5 Porter’s Five Forces Analysis
           6.5.1 Threat of New Entrants
           6.5.2 Threat of Substitutes
           6.5.3 Bargaining Power of Suppliers
           6.5.4 Bargaining Power of Buyers
           6.5.5 Intensity of Competitive Rivalry

7 Global Preclinical Imaging Market, By Modality (Page No. - 54)
    7.1 Introduction
    7.2 Optical Imaging Systems
           7.2.1 Bioluminescence/Fluorescence Imaging Systems
           7.2.2 Standalone Fluorescence Imaging Systems
           7.2.3 (Optical + X-Ray)/(Optical + CT) Systems
    7.3 Nuclear Imaging Systems
           7.3.1 Micro-PET Systems
                    7.3.1.1 Standalone PET Systems
                    7.3.1.2 PET/CT Systems
                    7.3.1.3 PET/MRI Systems
           7.3.2 Micro-Spect Systems
                    7.3.2.1 Standalone Spect Systems
                    7.3.2.2 Spect/CT Systems
                    7.3.2.3 Spect/MRI Systems
           7.3.3 Trimodality (Spect/PET/CT) Systems
    7.4 Micro-MRI
    7.5 Micro-Ultrasound
    7.6 Micro-CT
    7.7 Photoacoustic Imaging Systems
    7.8 Magnetic Particle Imaging (MPI) Systems

8 Global Preclinical Imaging Market, By Reagent (Page No. - 73)
    8.1 Introduction
    8.2 Preclinical Optical Imaging Reagents
           8.2.1 Bioluminescent Imaging Reagents
                    8.2.1.1 Luciferins
                    8.2.1.2 Proluciferins
                    8.2.1.3 Coelenterazine
                    8.2.1.4 Other Bioluminescent Imaging Reagents
           8.2.2 Fluorescent Imaging Reagents
                    8.2.2.1 Green Fluorescent Proteins
                    8.2.2.2 Red Fluorescent Proteins
                    8.2.2.3 Infrared Dyes
                    8.2.2.4 Other Fluorescent Imaging Reagents
    8.3 Preclinical Nuclear Imaging Reagents
           8.3.1 Preclinical PET Tracers
                    8.3.1.1 Fluorine-18-Based Preclinical PET Tracers
                    8.3.1.2 Carbon-11-Based Preclinical PET Tracers
                    8.3.1.3 Copper-64-Based Preclinical PET Tracers
                    8.3.1.4 Other PET Tracers
           8.3.2 Preclinical Spect Probes
                    8.3.2.1 Technetium-99m-Based Preclinical Spect Probes
                    8.3.2.2 Iodine-131-Based Preclinical Spect Probes
                    8.3.2.3 Gallium-67-Based Preclinical Spect Probes
                    8.3.2.4 Thallium-201-Based Preclinical Spect Probes
                    8.3.2.5 Other Spect Probes
    8.4 Preclinical MRI Contrast Agents
           8.4.1 Gadolinium-Based Preclinical Contrast Agents
           8.4.2 Iron-Based Preclinical Contrast Agents
           8.4.3 Manganese-Based Preclinical Contrast Agents
    8.5 Preclinical Ultrasound Contrast Agents
    8.6 Preclinical CT Contrast Agents
           8.6.1 Iodine-Based Preclinical CT Contrast Agents
           8.6.2 Barium-Based Preclinical CT Contrast Agents
           8.6.3 Gold Nanoparticles
           8.6.4 Gastrografin-Based Preclinical CT Contrast Agents

9 Preclinical Imaging Market, By Region (Page No. - 105)
    9.1 Introduction
    9.2 North America
    9.3 Europe
    9.4 Asia-Pacific
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 120)
     10.1 Overview
     10.2 Preclinical Imaging Market Share Analysis, By Key Player, 2015
     10.3 Competitive Scenario
             10.3.1 New Product Launches
             10.3.2 Agreements, Partnerships, and Collaborations
             10.3.3 Geographical Expansions
             10.3.4 Acquisitions

11 Company Profiles (Page No. - 127)
     11.1 Introduction
             11.1.1 Geographic Benchmarking
     11.2 Perkinelmer, Inc.
             11.2.1 Business Overview
             11.2.2 Products Offered
             11.2.3 Recent Developments (2013-2016)
             11.2.4 MnM View
     11.3 Bruker Corporation
             11.3.1 Business Overview
             11.3.2 Products Offered
             11.3.3 Recent Developments (2013-2016)
             11.3.4 MnM View
     11.4 Fujifilm Holdings Corporation
             11.4.1 Business Overview
             11.4.2 Products Offered
             11.4.3 Recent Developments (2013-2016)
             11.4.4 MnM View
     11.5 Mediso Ltd.
             11.5.1 Business Overview
             11.5.2 Products Offered
             11.5.3 Recent Developments (2013-2016)
     11.6 Milabs B.V.
             11.6.1 Business Overview
             11.6.2 Products Offered
             11.6.3 Recent Developments (2013-2016)
     11.7 MR Solutions Ltd.
             11.7.1 Business Overview
             11.7.2 Products Offered
             11.7.3 Recent Developments (2013-2016)
     11.8 Aspect Imaging Ltd.
             11.8.1 Business Overview
             11.8.2 Products Offered
             11.8.3 Recent Developments (2013-2016)
     11.9 Li-Cor Biosciences
             11.9.1 Business Overview
             11.9.2 Products Offered
             11.9.3 Recent Developments (2013-2016)
     11.10 Trifoil Imaging
             11.10.1 Business Overview
             11.10.2 Products Offered
             11.10.3 Recent Developments (2013-2016)
     11.11 Miltenyi Biotec GmbH
             11.11.1 Business Overview
             11.11.2 Products Offered
             11.11.3 Recent Developments (2013-2016)

12 Appendix (Page No. - 152)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports


List of Tables (83 Tables)

Table 1 Preclinical Imaging Systems Market Size, By Modality, 2014–2021 (USD Million)
Table 2 Global Optical Imaging Systems Market Size, By Type, 2014–2021 (USD Million)
Table 3 Optical Imaging Systems Market Size, By Region, 2014–2021 (USD Million)
Table 4 Bioluminescence/Fluorescence Imaging Systems Market Size, By Region, 2012–2014 (USD Million)
Table 5 Standalone Fluorescence Imaging Systems Market Size, By Region, 2012–2014 (USD Million)
Table 6 Optical + X-Ray/Optical + CT Imaging Systems Market Size, By Region, 2012–2014 (USD Million)
Table 7 Global Nuclear Imaging Systems Market Size, By Type, 2014–2021 (USD Million)
Table 8 Nuclear Imaging Systems Market Size, By Region, 2014–2021 (USD Million)
Table 9 Global Micro-PET Systems Market Size, By Type, 2014–2021 (USD Million)
Table 10 Micro-PET Systems Market Size, By Region, 2014–2021 (USD Million)
Table 11 Standalone PET Systems Market Size, By Region, 2014–2021 (USD Million)
Table 12 PET/CT Systems Market Size, By Region, 2014–2021 (USD Million)
Table 13 PET/MRI Systems Market Size, By Region, 2014–2021 (USD Million)
Table 14 Global Micro-Spect Systems Market Size, By Type, 2014–2021 (USD Million)
Table 15 Micro-Spect Systems Market Size, By Region, 2014–2021 (USD Million)
Table 16 Standalone Spect Systems Market Size, By Region, 2014–2021 (USD Million)
Table 17 Spect/CT Systems Market Size, By Region, 2014–2021 (USD Million)
Table 18 Spect/MRI Systems Market Size, By Region, 2014–2021 (USD Million)
Table 19 Trimodality Systems Market Size, By Region, 2014–2021 (USD Million)
Table 20 Micro-MRI Systems Market Size, By Region, 2014–2021 (USD Million)
Table 21 Micro-Ultrasound Systems Market Size, By Region, 2014–2021 (USD Million)
Table 22 Micro-CT Systems Market Size, By Region, 2014–2021 (USD Million)
Table 23 Photoacoustic Imaging Systems Market Size, By Region, 2014–2021 (USD Million)
Table 24 Magnetic Particle Imaging Systems Market Size, By Region, 2014–2021 (USD Million)
Table 25 Global Preclinical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 26 Global Preclinical Optical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 27 Preclinical Optical Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 28 Global Preclinical Bioluminescent Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 29 Preclinical Bioluminescent Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 30 Preclinical Luciferins Market Size, By Region, 2014–2021 (USD Million)
Table 31 Preclinical Proluciferins Market Size, By Region, 2014–2021 (USD Million)
Table 32 Preclinical Coelenterazine Market Size, By Region, 2014–2021 (USD Million)
Table 33 Other Preclinical Bioluminescent Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 34 Global Preclinical Fluorescent Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 35 Preclinical Fluorescent Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 36 Preclinical Green Fluorescent Proteins Market Size, By Region, 2014–2021 (USD Million)
Table 37 Preclinical Red Fluorescent Proteins Market Size, By Region, 2014–2021 (USD Million)
Table 38 Preclinical Infrared Dyes Market Size, By Region, 2014–2021 (USD Million)
Table 39 Other Preclinical Fluorescent Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 40 Global Preclinical Nuclear Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 41 Preclinical Nuclear Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 42 Global Preclinical PET Tracers Market Size, By Type, 2014–2021 (USD Million)
Table 43 Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 44 Fluorine-18-Based Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 45 Carbon-11-Based Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 46 Copper-64-Based Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 47 Other Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 48 Global Preclinical Spect Probes Market Size, By Type, 2014–2021 (USD Million)
Table 49 Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 50 Technetium-99m-Based Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 51 Iodine-131-Based Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 52 Gallium-67-Based Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 53 Thallium-201-Based Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 54 Other Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 55 Global Preclinical MRI Contrast Agents Market Size, By Type, 2014–2021 (USD Million)
Table 56 Preclinical MRI Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 57 Gadolinium-Based Preclinical Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 58 Iron-Based Preclinical Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 59 Manganese-Based Preclinical Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 60 Preclinical Ultrasound Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 61 Global Preclinical CT Contrast Agents Market Size, By Type, 2014–2021 (USD Million)
Table 62 Preclinical CT Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 63 Iodine-Based Preclinical CT Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 64 Barium-Based Preclinical CT Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 65 Gold Nanoparticles Market Size, By Region, 2014–2021 (USD Million)
Table 66 Gastrografin-Based Preclinical CT Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 67 Global Preclinical Imaging Systems and Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 68 North America: Preclinical Imaging Market Size, By Product, 2014–2021 (USD Million)
Table 69 North America: Preclinical Imaging Systems Market Size, By Modality, 2014–2021 (USD Million)
Table 70 North America: Preclinical Imaging Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 71 Europe: Preclinical Imaging Market Size, By Product, 2014–2021 (USD Million)
Table 72 Europe: Preclinical Imaging Systems Market Size, By Modality, 2014–2021 (USD Million)
Table 73 Europe: Preclinical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 74 Asia-Pacific: Preclinical Imaging Market Size, By Product, 2014–2021 (USD Million)
Table 75 Asia-Pacific: Preclinical Imaging Systems Market Size, By Modality, 2014-2021 (USD Million)
Table 76 Asia-Pacific: Preclinical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 77 RoW: Preclinical Imaging Market Size, By Product, 2014–2021 (USD Million)
Table 78 RoW: Preclinical Imaging Systems Market Size, By Modality, 2014-2021 (USD Million)
Table 79 RoW: Preclinical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 80 Top New Product Launches, 2013–2016
Table 81 Top Agreements, Partnerships, and Collaborations, 2013–2016
Table 82 Top Geographical Expansions, 2013–2016
Table 83 Top Acquisitions, 2013–2016


List of Figures (39 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 3 Pre-clinical Imaging Systems Market: Bottom-Up Approach
Figure 4 Pre-clinical Imaging Systems Market: Top-Down Approach
Figure 5 Pre-clinical Imaging Reagents Market: Top-Down Approach
Figure 6 Preclinical Imaging Market: Data Triangulation
Figure 7 Global Preclinical Imaging Systems Market, By Modality, 2016 vs 2021 (USD Million)
Figure 8 Global Preclinical Imaging Reagents Market, By Type, 2016 vs 2021 (USD Million)
Figure 9 Global Preclinical Imaging Market, By Region, 2016 (USD Million)
Figure 10 Technological Advancements in Molecular Imaging and Increasing Demand for Noninvasive Techniques—Key Market Drivers
Figure 11 North America is Expected to Dominate the Preclinical Imaging Market in 2016
Figure 12 Optical Imaging, Nuclear Imaging, and Micro-MRI Systems to Dominate the Preclinical Imaging Systems Market Till 2021
Figure 13 Optical Imaging and Nuclear Imaging Reagents to Dominate the Preclinical Imaging Reagents Market Till 2021
Figure 14 North America to Command the Largest Share of the Preclinical Imaging Market in 2016
Figure 15 Technological Advancements & Emerging Application Segments to Drive the Growth of the Preclinical Imaging Market Till 2021
Figure 16 Healthcare Expenditure Across Major Countries, 2000–2013
Figure 17 Majority of Product Value of Preclinical Imaging Systems is Added During the Manufacturing and Assembly Phase
Figure 18 Market Players Prefer Both Direct & Indirect Distribution Strategies
Figure 19 Porter’s Five Forces Analysis: Preclinical Imaging Market (2015)
Figure 20 Optical Imaging Systems to Dominate Preclinical Imaging Systems Market Till 2021
Figure 21 Optical Imaging Systems Market, By Type
Figure 22 Nuclear Imaging Systems Market, By Type
Figure 23 Preclinical Imaging Reagents Market, By Type
Figure 24 Preclinical Optical Imaging Reagents Market, By Type, 2016 vs 2021 (USD Million)
Figure 25 Preclinical Nuclear Imaging Reagents Market, By Type, 2016 vs 2021 (USD Million)
Figure 26 Preclinical MRI Contrast Agents Market, By Type, 2016 vs 2021 (USD Million)
Figure 27 Preclinical CT Contrast Agents Market, By Type, 2016 vs 2021 (USD Million)
Figure 28 Asia-Pacific to Be the Fastest-Growing Region in Global Preclinical Imaging Market Till 2021
Figure 29 North America: Preclinical Imaging Market Snapshot
Figure 30 Europe: Preclinical Imaging Market Snapshot
Figure 31 Asia-Pacific: Preclinical Imaging Market Snapshot (2016-2021)
Figure 32 RoW: Preclinical Imaging Market Snapshot (2016-2021)
Figure 33 New Product Launches: Key Growth Strategy Adopted By Majority of Market Players (2013-2016)
Figure 34 Global Preclinical Imaging Market Share, By Key Player (2015)
Figure 35 Increasing Number of New Products Launched is Stimulating the Preclinical Imaging Market Growth
Figure 36 Geographic Revenue Mix of the Top 3 Market Players (2015)
Figure 37 Perkinelmer, Inc.: Company Snapshot
Figure 38 Bruker Corporation: Company Snapshot
Figure 39 Fujifilm Holdings Corporation: Company Snapshot

The global preclinical imaging market is expected to reach a value of USD 910.4 Million by 2021; growing  at a CAGR of 6.2% during 2016-2021. A number of factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches are propelling the growth of the global preclinical imaging market. However, factors such as strict regulatory framework that governs preclinical researches, and significant installation and operational costs associated with preclinical imaging modalities are some of the major factors restraining the growth of this market. In addition to this, technological & procedural limitations associated with standalone systems is a major challenge for players in this market.

On the basis of products, the global preclinical imaging market is segmented into two major categories, namely, modality (optical imaging systems, nuclear imaging systems, micro-MRI systems, micro-Ultrasound systems, micro-CT systems, photoacoustic imaging systems, and magnetic particle imaging systems) and reagents (optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents). The modalities segment is expected to grow at the higher CAGR in the next five years, owing to the extensive application of imaging systems in preclinical research studies across the globe, high cost of systems, and the development & commercialization of technologically advance novel preclinical imaging technologies.

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, the global preclinical imaging market is expected to be dominated by North America. A number of factors such as robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems are driving the growth of the preclinical imaging market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. This is primarily due to the continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries.

Preclinical Imaging (In-VIVO) Market

New product launches and product enhancements are the key growth strategies adopted by major players to develop their positions in the global preclinical imaging market. Moreover, strategies such as geographic expansions; and partnerships, agreements, and collaborations; acquisitions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the global preclinical imaging market.

As of 2015, PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), Aspect Imaging (Israel), LI-COR Biosciences (U.S.), Trifoil Imaging (U.S.) and Miltenyi Biotec GmbH (Germany) are some key players operating in the global preclinical imaging market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Diagnostic Imaging Markets on KnowledgeStore
Request Demo